Johnson & Johnson (NY:JNJ)
Delayed: 88.46 --0 (-0%)
Trade Now!
Previous Close $88.46    52 Week High $89.99 
Open $88.70    52 Week Low $61.71 
Day High $89.99    P/E 24.10 
Day Low $88.20    EPS $3.67 
Volume 13,827,735       

Friends, Peers and Foes (?): PFE, MDVN, ABT, GE, MRK (more...)

May 21, 2013 02:05 AM Cordis Showcases Cardiovascular Innovations at EuroPCR 2013
May 15, 2013 06:19 PM Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data
May 15, 2013 04:41 PM Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013 04:15 PM SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis
May 13, 2013 05:16 PM Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter
May 13, 2013 08:04 AM J&J's (JNJ) Janssen Receives Priority Review from FDA for Simeprevir
May 13, 2013 08:01 AM U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
May 9, 2013 09:49 AM First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation
May 9, 2013 09:01 AM Human Performance Institute Division of Johnson & Johnson’s Wellness & Prevention, Inc. Announces New, Web-based Energy Management Program
May 8, 2013 03:32 PM Form 4 JOHNSON & JOHNSON For: May 07 Filed by: CULLEN JAMES
View All Articles

Entities mentioned with JNJ

View All Entities